Alberto Chervín

1.1k total citations
24 papers, 805 citations indexed

About

Alberto Chervín is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Alberto Chervín has authored 24 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Alberto Chervín's work include Pituitary Gland Disorders and Treatments (18 papers), Growth Hormone and Insulin-like Growth Factors (12 papers) and TGF-β signaling in diseases (5 papers). Alberto Chervín is often cited by papers focused on Pituitary Gland Disorders and Treatments (18 papers), Growth Hormone and Insulin-like Growth Factors (12 papers) and TGF-β signaling in diseases (5 papers). Alberto Chervín collaborates with scholars based in Argentina, Germany and Spain. Alberto Chervín's co-authors include Eduardo Arzt, Marcelo Páez-Pereda, Günter K. Stalla, Victoria Goldberg, Ulrich Renner, Alberto Carbia Nagashima, Damiana Giacomini, Damián Refojo, Tien‐Chun Chang and Hakim Bouterfa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.

In The Last Decade

Alberto Chervín

24 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alberto Chervín Argentina 13 581 244 187 115 114 24 805
Carole Auger France 15 369 0.6× 205 0.8× 207 1.1× 113 1.0× 174 1.5× 31 753
Ricardo V. Lloyd United States 8 543 0.9× 182 0.7× 178 1.0× 161 1.4× 230 2.0× 10 705
Alejandro Ibáñez‐Costa Spain 18 391 0.7× 312 1.3× 140 0.7× 299 2.6× 80 0.7× 49 902
Emilia Ballarè Italy 13 368 0.6× 347 1.4× 114 0.6× 167 1.5× 59 0.5× 14 757
Shunji Yunoue Japan 16 204 0.4× 237 1.0× 124 0.7× 150 1.3× 190 1.7× 26 733
Annett Hölsken Germany 16 659 1.1× 334 1.4× 202 1.1× 122 1.1× 391 3.4× 25 875
A. M. Landolt Switzerland 15 569 1.0× 125 0.5× 180 1.0× 263 2.3× 82 0.7× 34 775
Nicole Moayeri United States 5 509 0.9× 93 0.4× 204 1.1× 117 1.0× 66 0.6× 7 673
Sophie Vallette-Kasic France 16 854 1.5× 401 1.6× 222 1.2× 31 0.3× 77 0.7× 23 1.2k
John Apps United Kingdom 15 166 0.3× 590 2.4× 76 0.4× 143 1.2× 152 1.3× 38 982

Countries citing papers authored by Alberto Chervín

Since Specialization
Citations

This map shows the geographic impact of Alberto Chervín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Chervín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Chervín more than expected).

Fields of papers citing papers by Alberto Chervín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Chervín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Chervín. The network helps show where Alberto Chervín may publish in the future.

Co-authorship network of co-authors of Alberto Chervín

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Chervín. A scholar is included among the top collaborators of Alberto Chervín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Chervín. Alberto Chervín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guitelman, Mirtha, Michael G. Vitale, Alberto Chervín, et al.. (2012). Primary empty sella (PES): a review of 175 cases. Pituitary. 16(2). 270–274. 1 indexed citations
2.
3.
Levalle, Oscar, et al.. (2009). Restoration and Maintenance of Spermatogenesis by HCG Therapy in Patients with Hypothalamo-Hypophyseal Damage. Andrologia. 16(4). 303–309. 3 indexed citations
4.
Mercado, Moisés, Hakim Bouterfa, Tien‐Chun Chang, et al.. (2007). A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long‐acting repeatable octreotide) in the primary therapy of patients with acromegaly. Clinical Endocrinology. 66(6). 859–868. 158 indexed citations
5.
Giacomini, Damiana, Marcelo Páez-Pereda, Marily Theodoropoulou, et al.. (2006). Bone Morphogenetic Protein-4 Control of Pituitary Pathophysiology. Frontiers of hormone research. 35. 22–31. 22 indexed citations
6.
Giacomini, Damiana, Marcelo Páez-Pereda, Marily Theodoropoulou, et al.. (2005). Bone Morphogenetic Protein-4 Inhibits Corticotroph Tumor Cells: Involvement in the Retinoic Acid Inhibitory Action. Endocrinology. 147(1). 247–256. 70 indexed citations
7.
Day, Patricia, et al.. (2005). Retrospective Multicentric Study of Pituitary Incidentalomas. Pituitary. 1 indexed citations
8.
Day, Patricia, et al.. (2004). Retrospective Multicentric Study of Pituitary Incidentalomas. Pituitary. 7(3). 145–148. 76 indexed citations
9.
Onofri, Chiara, Alberto Carbia Nagashima, Ludwig Schaaf, et al.. (2004). Estradiol Stimulates Vascular Endothelial Growth Factor and Interleukin-6 in Human Lactotroph and Lactosomatotroph Pituitary Adenomas. Experimental and Clinical Endocrinology & Diabetes. 112(1). 18–23. 23 indexed citations
10.
Fideleff, Hugo, et al.. (2004). Adult growth hormone deficiency. Metabolic alterations and evaluation of different risk groups.. PubMed. 64(1). 13–9. 4 indexed citations
12.
Páez-Pereda, Marcelo, P. Lohrer, Damián Kovalovsky, et al.. (2000). Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas. Experimental and Clinical Endocrinology & Diabetes. 108(3). 202–207. 44 indexed citations
13.
Castro, Carolina Perez, Alberto Carbia Nagashima, Marcelo Páez-Pereda, et al.. (2000). The gp130 Cytokines Interleukin-11 and Ciliary Neurotropic Factor Regulate through Specific Receptors the Function and Growth of Lactosomatotropic and Folliculostellate Pituitary Cell Lines*. Endocrinology. 141(5). 1746–1753. 32 indexed citations
14.
Páez-Pereda, Marcelo, Victoria Goldberg, Alberto Chervín, et al.. (2000). High Levels of Matrix Metalloproteinases Regulate Proliferation and Hormone Secretion in Pituitary Cells1. The Journal of Clinical Endocrinology & Metabolism. 85(1). 263–269. 72 indexed citations
15.
Jasper, Héctor, P. Pennisi, Michela Vitale, et al.. (1999). Evaluation of disease activity by IGF-I and IGF binding protein-3 (IGFBP3) in acromegaly patients distributed according to a clinical score. Journal of Endocrinological Investigation. 22(1). 29–34. 12 indexed citations
16.
Vindrola, Osvaldo, et al.. (1998). Elevated Proenkephalin-Derived Peptide Levels in ACTH-Producing Adenomas: Nucleus and Cytoplasm Localization. Endocrine. 8(3). 231–240. 6 indexed citations
17.
Fideleff, Hugo, et al.. (1997). Tratamiento de amenorreas hiperprolactinemicas con cabergolina. Medicina-buenos Aires. 57(6). 657–661. 1 indexed citations
18.
Fideleff, Hugo, et al.. (1997). [Treatment of hyperprolactinemic amenorrhea with cabergoline].. PubMed. 57(6). 657–61. 2 indexed citations
19.
Páez-Pereda, Marcelo, Victoria Goldberg, Alberto Chervín, et al.. (1996). Interleukin-2 (IL-2) and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants. Molecular and Cellular Endocrinology. 124(1-2). 33–42. 40 indexed citations
20.
Chervín, Alberto, et al.. (1993). Human pituitary tumours: Studies on genes expression. Neurological Research. 15(1). 2–6. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026